Higher coffee intake is associated with lower visceral fat despite similar body mass index

1. A Finnish cohort study of 2,264 adults found that higher coffee intake was associated with lower total and visceral fat and greater skeletal muscle mass despite similar body mass index, suggesting a body composition difference that body mass index alone would not capture.

2. The study is cross-sectional and cannot establish causation, but the findings complement prospective evidence linking coffee consumption with lower type 2 diabetes risk and identify branched-chain amino acids and sex hormone profiles as potential metabolic correlates.

Finland’s unusually high habitual coffee consumption makes the Northern Finland Birth Cohort 1966 a useful population for examining how long-term coffee habits correlate with metabolic health beyond body weight alone. Researchers analyzed 2,264 participants at age 46, comparing reported coffee intake with body composition, circulating metabolites, glucose and insulin measures, and sex hormone profiles. Importantly, body composition was measured using bioelectrical impedance analysis, not dual-energy X-ray absorptiometry, with participants categorized as consuming one to two, three to four, or at least five cups of coffee daily. Higher coffee intake was associated with lower body fat percentage, lower fat mass, lower visceral fat area, and greater skeletal muscle mass despite broadly similar body mass index (BMI), showing how potentially meaningful differences in adiposity can be obscured when BMI is considered alone. The metabolic profile moved in the same direction, with higher coffee consumption associated with lower circulating branched-chain amino acids (BCAAs), metabolites that have repeatedly been associated with insulin resistance and future metabolic disease. In men, each additional daily cup was associated with approximately 0.29 nmol/L higher total testosterone and 0.57 nmol/L higher sex hormone-binding globulin, although the simultaneous inverse associations with free androgen measures make a simple testosterone-mediated explanation for greater muscle mass difficult to support. Coffee contains caffeine, chlorogenic acids, and numerous other bioactive compounds capable of affecting glucose metabolism, energy expenditure, and oxidative pathways, but this study was not designed to establish which, if any, produced the observed body composition differences. The findings are nevertheless directionally consistent with prospective epidemiology showing an inverse association between coffee intake and diabetes risk across both caffeinated and decaffeinated coffee consumption.

The central limitation is the cross-sectional design, which makes reverse causation and residual confounding impossible to exclude even after adjustment for body mass index, education, smoking, physical activity, and alcohol consumption. Coffee drinkers may differ in diet, occupational patterns, sleep, socioeconomic factors, or other behaviors that could contribute to the observed differences in adiposity and muscle mass, while bioelectrical impedance itself provides an indirect estimate of body composition influenced by assumptions about hydration and tissue conductivity. The results therefore should not be interpreted as evidence that increasing coffee intake will reduce visceral fat or increase skeletal muscle mass, nor do they establish coffee as a weight-management intervention. They do, however, add a body composition signal to a broader observational literature in which habitual coffee consumption has repeatedly tracked with favorable cardiometabolic outcomes. For most healthy adults, moderate coffee intake remains compatible with current safety guidance, with up to 400 milligrams of caffeine per day generally not associated with negative effects, although individual sensitivity, pregnancy, medications, arrhythmias, anxiety, and sleep effects can change that calculation. The clinically useful takeaway is not to prescribe coffee for visceral adiposity, but to recognize that habitual coffee consumption appears metabolically neutral to favorable in observational data and that body mass index alone may miss potentially important differences in fat distribution and lean mass.

Image: PD

©2026 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.